Merck & Co. Inc. has officially washed its hands of a once-lauded experimental cancer drug it invested in along with Ariad Pharmaceuticals Inc. Merck informed Ariad last week that it was terminating its license agreement and handing back the drug to Ariad, FierceBiotech reports.
http://ift.tt/1eh8Q4M
http://ift.tt/1eh8Q4M
No comments:
Post a Comment